Summit Cancer Centers is First in the Inland Northwest to Obtain a New Generation of Dual Immunotherapy Trials for First Line Metastatic Non-Small Cell Lung Cancer. Immunotherapy has revolutionized the treatment of metastatic non-small cell lung cancer. However, not every patient responds to single agent immunotherapy, either alone or in…
Read more Share

Summit Cancer Centers is first in Washington to offer the Phase 3 Clinical Trial of Immunotherapy AM0010 for Metastatic Adenocarcinoma of the Pancreas. “We are proud to offer an immunotherapy trial for advanced adenocarcinoma of the pancreas,” states Dr. Arvind Chaudhry, Director of Research at Summit Cancer Centers. Current treatments…
Read more Share

Summit Cancer Centers is first in the nation to offer Duvelisib, a new Lymphoma drug trial for patients with CLL who have experienced relapse on Ibrutinib. FDA approval of Imbruvica (ibrutinib) in February of 2014 revolutionized the treatment and outcome of patients with chronic lymphocytic lymphoma (CLL). Median survival rates of…
Read more Share

Summit Cancer Centers are  first in Spokane to offer a powerful new dual immunotherapy clinical trial in the treatment of advanced kidney cancer. The significant challenge with kidney cancer is that patients are often diagnosed at an advanced stage, and therefore, are very sick at their initial clinical visit. “We wanted options…
Read more Share

Summit Cancer Center is proud to be the first in a six state region to molecularly target a resistant form of colorectal cancer. Colorectal cancers with BRAF mutations have long been known to be resistant, or quickly recur, following conventional chemotherapy. Array Biopharma is testing a molecular combination that specifically…
Read more Share

Dr. Arvind Chaudhry was recently invited by Bayer to educate physicians on the new lymphoma therapy, Aliqopa. Dr. Arvind Chaudhry, medical oncologist and medical director of Summit Cancer Centers, was recently invited to educate physicians on the FDA approval of the follicular lymphoma drug, Aliqopa (copanlisib). Aliqopa belongs to a new class of drugs that…
Read more Share

Join us for a free wellness conference designed to provide education on wellness after cancer. Saturday, Sept. 23, 2017 All cancer patients, survivors, caregivers, friends, families and healthcare professionals are invited to attend this wellness conference. Lunch will be provided, plus raffle prizes and swag provided by local vendors. This…
Read more Share

Summit Cancer Centers and Seattle Cancer Care Alliance are Sponsors of the 2017 Bloomsday Race Crew Party. Summit Cancer Centers and Seattle Cancer Care Alliance are very proud to co-sponsor the 2017 Bloomsday Race Crew  dinner to celebrate the contributions of approximately 700 Bloomsday volunteers. All of the volunteers’ efforts…
Read more Share

Local Survivors  and Advocates will Unite at Summit for the Nation’s Largest Lung Cancer Awareness Event. In recognition of November’s Lung Cancer Awareness Month, Summit Cancer Centers is very proud to host the 8th Annual Shine a Light on Lung Cancer event for the first  time in North Idaho. On…
Read more Share

CyberKnife®  offers new hope to cancer patients diagnosed with Brain Metastases. Metastatic brain cancer occurs when cancer spreads to the brain from another part of the body. Approximately 20-40% of people with cancer will develop brain metastases. The most common types of cancer to spread to the brain are lung…
Read more Share